Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
63 studies found for:    antineoplastons
Show Display Options
RSS Create an RSS feed from your search for:
antineoplastons
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
Condition: Brain Stem Gliomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
2 Completed
Has Results
Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Condition: Mixed Gliomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
3 Completed
Has Results
Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Condition: Low Grade Astrocytomas
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
4 Completed
Has Results
Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors
Condition: Childhood CNS Primitive Neuroectodermal Tumor
Intervention: Drug: Antineoplaston therapy (Atengenal + Astugenal)
5 Not yet recruiting Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
6 Not yet recruiting Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma
Condition: Brain Stem Glioma
Interventions: Radiation: Radiation;   Drug: Atengenal;   Drug: Astugenal
7 Unknown  Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
Condition: Liver Cancer
Intervention: Drug: antineoplaston A10
8 Unknown  Antineoplaston Therapy in Treating Children With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
9 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
10 Unknown  Antineoplaston Therapy in Treating Patients With Ependymoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
11 Unknown  Antineoplaston Therapy in Treating Patients With Meningioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
12 Terminated Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
13 Unknown  Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
14 Completed Antineoplaston Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
15 Unknown  Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: Sarcoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
16 Unknown  Antineoplaston Therapy in Treating Patients With Stomach Cancer
Condition: Gastric Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
17 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer
Condition: Lung Cancer
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
18 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Conditions: Kidney Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
19 Unknown  Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
20 Unknown  Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.